INCOME TAXES (Tables)

12 Months Ended

Aug. 31, 2019

Major components of tax expense (income) [abstract]

Disclosure of detailed information about components of deferred income tax expense [Table Text Block]

		AUGUST 31, 2019		AUGUST 31, 2018
Origination and reversal of temporary differences	$	1,987	$	8,644
Change in tax rate and rate differences		281		178
Change in unrecognized temporary differences		1,349		(3,165	)
Prior period adjustments		12		(4	)
Total income tax expense		3,629		5,653

Disclosure of detailed information about reconciliation of income tax expense [Table Text Block]

		AUGUST 31, 2019			AUGUST 31, 2018
Income (loss) from continuing operations before income taxes	$	(5,875	)	$	27,777
Statutory rate		29.00%			29.00%
Tax calculated at statutory rate		(1,704	)		8,055
Non-deductible (non-taxable) items		3,742			742
Difference between current and future tax rates		281			74
Benefit of deductible temporary differences not recognized		1,349			(3,165	)
Other		(39	)		(53	)
Income tax expense per financial statements	$	3,629		$	5,653

Disclosure of detailed information about recognized deferred tax assets and liabilities [Table Text Block]

		AUGUST 31, 2019			AUGUST 31, 2018
Deferred tax assets are attributable to the following:
Non-capital losses	$	10,708		$	8,604
Share issuance costs		-			1,657
		-			32
Deferred tax assets		10,708			10,293
Set-off of tax		(10,708	)		(10,293	)
Net deferred tax asset	$	-		$	-
Deferred tax liabilities are attributable to the following:
Long-term assets	$	(4,983	)	$	(1,275	)
Biological assets		(961	)		(3,307	)
Inventories		(15,200	)		(10,385	)
Unsecured convertible debentures		-			(3,306	)
Other		(35	)		-
Deferred tax liabilities		(21,179	)		(18,273	)
Set-off of tax		10,708			10,293
Net deferred tax liability	$	(10,471	)	$	(7,980	)

Disclosure Of Detailed Information About Changes In Temporary Differences In Net Tax Assets Liabilities Explanatory

		NET BALANCE AT AUGUST 31, 2018			RECOGNIZED IN PROFIT OR LO SS			RECOGNIZED DIRECTLY IN EQUITY & OCI			NET BALANCE AT AUGUST 31, 2019
Non-capital losses	$	8,604		$	2,723		$	(619	)	$	10,708
Share issuance costs		1,657			-			(1,657	)		-
PP&E		(1,275	)		(3,708	)		-			(4,983	)
Biological assets		(3,307	)		2,346			-			(961	)
Inventories		(10,385	)		(4,815	)		-			(15,200	)
Unsecured convertible debentures		(3,306	)		(108	)		3,414			-
Other		32			(67	)		-			(35	)
Net tax assets (liabilities)	$	(7,980	)	$	(3,629	)	$	1,138		$	(10,471	)
		NET BALANCE AT AUGUST 31, 2017			RECOGNIZED IN PROFIT OR LO SS			RECOGNIZED DIRECTLY IN EQUITY & OCI			NET BALANCE AT AUGUST 31, 2018
Non-capital losses	$	132		$	7,797		$	675		$	8,604
Share issuance costs		-			-			1,657			1,657
PP&E		(132	)		(1,143	)		-			(1,275	)
Biological assets		-			(3,307	)		-			(3,307	)
Inventories		-			(10,385	)		-			(10,385	)
Unsecured convertible debentures		-			1,353			(4,659	)		(3,306	)
Other		-			32			-			32
Net tax assets (liabilities)	$	-		$	(5,653	)	$	(2,327	)	$	(7,980	)

Disclosure of detailed information about non-capital losses [Table Text Block]

		AUGUST 31, 2019
August 31, 2035	$	1,070
August 31, 2037		11,727
August 31, 2038		16,690
August 31, 2039		11,562
	$	41,049

Disclosure of detailed information about unrecognized deductible temporary differences and unused tax losses [Table Text Block]

		AUGUST 31, 2019		AUGUST 31, 2018
Deductible temporary differences	$	12,010	$	1,467
Tax losses		3,809		1,219
	$	15,819	$	2,686